Limited beneficial effects of piceatannol supplementation on obesity complications in the obese Zucker rat: gut microbiota, metabolic, endocrine, and cardiac aspects

Hijona E, Aguirre L, Pérez-Matute P, Villanueva-Millán MJ, Mosqueda-Solis A, Hasnaoui M, Nepveu F, Senard JM, Bujanda L, Aldámiz-Echevarría L, Llarena M, Andrade F, Perio P, Leboulanger F, Hijona L, Arbones-Mainar JM, Portillo MP, Carpéné C.

J Physiol Biochem. 2016 Sep; 72(3):567-82. DOI: 10.1007/s13105-015-0464-2.

30/09/16

Identification and Characterization of the Dermal Panniculus Carnosus Muscle Stem Cells

Naldaiz-Gastesi N, Goicoechea M, Alonso-Martín S, Aiastui A, López-Mayorga M, García-Belda P, Lacalle J, San José C, Araúzo-Bravo MJ, Trouilh L, Anton-Leberre V, Herrero D, Matheu A, Bernad A, García-Verdugo JM, Carvajal JJ, Relaix F, Lopez de Munain A, García-Parra P, Izeta A.

Stem Cell Reports. 2016; 7: 411-424. FI: 7,338(Q1). DOI: 10.1016/j.stemcr.2016.08.002.

30/06/16

Potential renoprotective effects of piceatannol in ameliorating the early-stage nephropathy associated with obesity in obese Zucker rats

Llarena M, Andrade F, Hasnaoui M, Portillo MP, Perez-Matute P, Arbones-Mainar JM, Hijona E, Villanueva-Millan, MJ, Aguirre L, Carpene C, Aldamiz-Echevarria L.

J Physiol Biochem. 2016; 72: 555-566. FI: 2,444(Q2). DOI: 10.1007/s13105-015-0457-1.

30/06/16

Potential renoprotective effects of piceatannol in ameliorating the early-stage nephropathy associated with obesity in obese Zucker rats

Llarena M, Andrade F, Hasnaoui M, Portillo MP, Pérez-Matute P, Arbones-Mainar JM, Hijona E, Villanueva-Millán MJ, Aguirre L, Carpéné C, Aldámiz-Echevarría L

J Physiol Biochem. 2015 Dec 10.

10/12/15

Manual Veterinario de las Aves Rapaces

Bañales A, Carrillo JA, San José C

1ª ed. MADRID: AEVA 2015 ISBN 978-608-2735-1.

30/06/15

Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease

Munoz-Garrido P, Marin JJ, Perugorria MJ, Urribarri AD, Erice O, Sáez E, Úriz M, Sarvide S, Portu A, Concepcion AR, Romero MR, Monte MJ, Santos-Laso Á, Hijona E, Jimenez-Agüero R, Marzioni M, Beuers U, Masyuk TV, LaRusso NF, Prieto J, Bujanda L, Drenth JP, Banales JM

J Hepatol. 2015; 63 (4): 952-61. doi: 10.1016/j.jhep.2015.05.023

30/06/15

Effects of resveratrol on obesity-related inflammation markers in adipose tissue of genetically obese rats.

Gómez-Zorita S, Fernández-Quintela A, Lasa A, Hijona E, Bujanda L, Portillo MP.

Nutrition. 2013 Nov-Dec;29(11-12):1374-80.

11/11/13

Several statins increase body and liver fat accumulation in a model of metabolic syndrome.

Aguirre L, Hijona E, Macarulla MT, Gracia A, Larrechi I, Bujanda L, Hijona L, Portillo MP

J Physiol Pharmacol. 2013 Jun;64(3):281-8.

13/06/13

Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress.

Gómez-Zorita S, Fernández-Quintela A,Macarulla MT, Aguirre L, Hijona E, Bujanda L, Milagro F, Martínez JA, Portillo MP.

British Journal of Nutrition

10/07/12

Standardization of the quantification of iron concentration in the liver by magnetic resonance imaging.

Alústiza JM, Emparanza JI, Aldazábal P, Garrido A, García N, Salvador E, San Vicente M; Grupo Burnia.

Radiologia.

05/04/12